o2h Ventures

o2h Ventures operates as a specialist venture capital firm, providing SEIS/EIS and growth-stage funds designed to propel biotech companies from their foundational seed stage through to clinical development. The firm’s core offering involves strategic investments into life science ventures, focusing on fostering innovation within the UK's burgeoning biotech ecosystem. They leverage a deep understanding of the sector to identify and support promising scientific breakthroughs.

The company was co-founded in 2013 by Sunil Shah and Prashant Shah. Sunil Shah, who also serves as the CEO of o2h Ventures and is a co-founder of the broader o2h Group, brought over two decades of experience within the biotech community to the venture. Their founding insight centered on a shared passion for nurturing and investing in nascent life science companies, aiming to bridge the critical funding gap for emerging biotech innovators.

o2h Ventures primarily serves visionary teams within the biotech sector, offering the capital and support needed to translate scientific discoveries into tangible applications. Their long-term vision is centered on transforming UK biotech breakthroughs into significant societal impact. The firm remains committed to facilitating the growth and development of innovative life science companies, ultimately advancing the frontier of biotechnology.